Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica A Pollard

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|March 28, 2014
Molecular therapeutic approaches for pediatric acute myeloid leukemiaSarah K Tasian, Jessica A Pollard, Richard Aplenc
Cold Spring Harbor Perspectives in Medicine|February 10, 2025
Genetic Predisposition to Hematologic MalignanciesKayla V Hamilton, Akiko Shimamura, Jessica A Pollard
Developmental Science|August 18, 2010
The role of competition in word learning via referent selectionJessica S Horst, Emilly J Scott, Jessica A Pollard
Pediatric Blood & Cancer|June 27, 2023
Impact of cytoreduction and remission status on hematopoietic cell transplantation outcomes in pediatric myelodysplastic syndrome and related disordersFranziska Wachter, Kyle Hebert, Yana Pikman, et al.
British Journal of Haematology|July 6, 2013
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology groupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Pediatric Blood & Cancer|July 21, 2023
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasmsTodd M Cooper, Todd A Alonzo, Sarah K Tasian, et al.
Pediatric Blood & Cancer|August 20, 2013
The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Pediatric Emergency Care|January 3, 2018
Improving Time to Antibiotics for Pediatric Oncology Patients With Suspected Infections: An Emergency Department-Based Quality Improvement InterventionHiromi Yoshida, Kasey J Leger, Min Xu, et al.
Blood|July 1, 2006
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemiaJessica A Pollard, Todd A Alonzo, Robert B Gerbing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Michael Loken, Robert B Gerbing, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|March 28, 2014
Molecular therapeutic approaches for pediatric acute myeloid leukemiaSarah K Tasian, Jessica A Pollard, Richard Aplenc
Cold Spring Harbor Perspectives in Medicine|February 10, 2025
Genetic Predisposition to Hematologic MalignanciesKayla V Hamilton, Akiko Shimamura, Jessica A Pollard
Developmental Science|August 18, 2010
The role of competition in word learning via referent selectionJessica S Horst, Emilly J Scott, Jessica A Pollard
Pediatric Blood & Cancer|June 27, 2023
Impact of cytoreduction and remission status on hematopoietic cell transplantation outcomes in pediatric myelodysplastic syndrome and related disordersFranziska Wachter, Kyle Hebert, Yana Pikman, et al.
British Journal of Haematology|July 6, 2013
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology groupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Pediatric Blood & Cancer|July 21, 2023
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasmsTodd M Cooper, Todd A Alonzo, Sarah K Tasian, et al.
Pediatric Blood & Cancer|August 20, 2013
The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Pediatric Emergency Care|January 3, 2018
Improving Time to Antibiotics for Pediatric Oncology Patients With Suspected Infections: An Emergency Department-Based Quality Improvement InterventionHiromi Yoshida, Kasey J Leger, Min Xu, et al.
Blood|July 1, 2006
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemiaJessica A Pollard, Todd A Alonzo, Robert B Gerbing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Michael Loken, Robert B Gerbing, et al.
Pageof 4